Neurokaire
Kearny, US · Founded 2017 · 46 employees on LinkedIn · 1 known investors
Find your way into Neurokaire
1,309 people in our graph share verified history with the Neurokaire team — schools, employers, funds. One of them is your warm intro.
Alex Chachavaunlockedknows Talia Cohen Solal · together at YPO (overlapped)
×7knows the team · via University of Oxford
×2knows the team · via Harvard Business School
knows the team · via Columbia University in the City of New York
knows the team · via University of Nebraska-Lincoln
NeuroKaire uses cellular modeling and biological measurement to help mental health providers and patients make treatment decisions for depression based on measurable biological response rather than trial-and-error approaches. The company offers diagnostic testing through CLIA-certified laboratories to provide earlier biological context for antidepressant selection.
Founders & leadership
Neurokaire was founded in 2017 by Talia Cohen Solal, Daphna Laifenfeld, and Issar Yazbin.
TC
Talia Cohen SolalinTalia Cohen Solal is a neuroscientist with a Ph.D. from UCL focused on mental illness mechanisms, postdoctoral research experience at Columbia University, and prior roles in personalized medicine biotech including as a principal scientist.
DL
Daphna LaifenfeldinDaphna Laifenfeld held executive roles in major pharmaceutical and healthcare companies, where she led teams and business units focused on personalized medicine and diagnostics. She has expertise in healthcare data analytics, diagnostic regulation, and market access strategy.
IY
Issar YazbininIssar Yazbin is a product and project management executive with experience in strategic planning, business development, and leadership across product P&L management, business strategy, and partnership building.
Investors · 1
Frequently asked questions
- What does Neurokaire do?
- NeuroKaire uses cellular modeling and biological measurement to help mental health providers and patients make treatment decisions for depression based on measurable biological response rather than trial-and-error approaches. The company offers diagnostic testing through CLIA-certified laboratories to provide earlier biological context for antidepressant selection.
- Who founded Neurokaire?
- Neurokaire was founded by Talia Cohen Solal, Daphna Laifenfeld, Issar Yazbin in 2017.
- Who are Neurokaire's investors?
- Neurokaire's investors include Meron Capital.
- Where is Neurokaire headquartered?
- Neurokaire is headquartered in Kearny, US.